P12493 (GAG_HV1N5) Human immunodeficiency virus type 1 group M subtype B (isolate NY5)(HIV-1)

Gag polyprotein UniProtKBInterProInteractive Modelling

500 aa; Sequence (Fasta) ; 1 identical sequence: Human immunodeficiency virus type 1: I6RF17

Available Structures

125 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Mature HIV-1 matrix from MA-SP1 cleavage mutant Heteromer
5-448
100
CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions Heteromer
133-354
98.12
CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions Heteromer
133-354
98.15
HIV-1 CA lattice bound to IP6; from capsid-like particles Heteromer
133-354
100.0
HIV-1 capsid lattice bound to IP6, pH 6.2 Heteromer
133-354
100.0
HIV-1 CA lattice bound to IP6, pH 7.4 Heteromer
133-354
100.0
HIV-1 capsid lattice bound to dNTPs Heteromer
133-354
100.0
HIV-1 capsid lattice bound to IP6 and Lenacapavir Heteromer
133-354
100.0
Structure of the native full-length HIV-1 capsid protein in complex with CPSF6 peptide Heteromer
Q16630;
133-353
100.036×IOD; 24×CL;
Structure of HIV-1 capsid declination in complex with CPSF6-FG peptide Heteromer
Q16630;
133-353
100.0
HIV-1 mature capsid pentamer from CA-IP6 CLPs Heteromer
133-353
100.0
HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to Nup153 peptide Heteromer
P49790;
133-353
100.0
HIV-1 mature capsid pentamer from CA-IP6 CLPs bound to Nup153 peptide Heteromer
133-353
100.0
HIV-1 mature capsid pentamer from CA-IP6 CLPs bound to Sec24C peptide Heteromer
133-353
100
HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to Sec24C peptide. Heteromer
P53992;
133-353
100.0
HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to CPSF6 peptide. Heteromer
Q16630;
133-353
100.0
HIV-1 mature capsid pentamer from CA-IP6 CLPs bound to CPSF6 peptide Heteromer
133-353
100
HIV-1 mature capsid hexamer next to pentamer (type I) from CA-IP6 CLPs bound to Nup153 peptide. Heteromer
P49790;
133-353
100.0
Hexameric HIV-1 CA in complex with CPSF6 peptide, P6 crystal form Heteromer
Q16630;
133-352
99.04CL;
Structural basis of HIV-1 capsid recognition by CPSF6 Heteromer
Q16630;
133-352
98.13
Hexamer HIV-1 CA in complex with CPSF6 peptide, P212121 crystal form Heteromer
Q16630;
133-352
98.08
Structure of M66I mutant of disulfide stabilized HIV-1 CA hexamer in complex with CPSF6 peptide and… Heteromer
Q16630;
133-352
97.47IHP;
Hexameric HIV-1 CA in complex with Nup153 peptide, P6 crystal form Heteromer
P49790;
133-351
99.05
HIV-1 CA hexamer with NUP153 peptide - P1 crystal form Heteromer
P49790;
133-351
98.17FLU;
Structure of the native full-length HIV-1 capsid protein in complex with Nup153 peptide Heteromer
P49790;
133-351
100.042×IOD; 12×CL;
HIV-1 CA hexamer with NUP153 peptide - R3 crystal form Heteromer
P49790;
133-351
98.09FLU;
Hexameric HIV-1 CA in complex with Nup153 peptide, P212121 crystal form Heteromer
P49790;
133-351
98.15CL;
HIV-1 CA 1/2-hexamer-EE Heteromer
133-351
98.51
Cysteine stabilized hexameric HIV-1 CA in complex with SEC24C peptide Heteromer
P53992;
144-353
98.0918×IOD; 18×CL;
Llama VHH in complex with p24 Heteromer
281-353
100
Structure of the complex between calmodulin and the binding domain of HIV-1 matrix protein Heteromer
P0DP29;
8-43
100CA;
T=1 particle HIV-1 CA G60A/G61Phomo-60-mer133-353
99.09120×IHP;
T=1 particle HIV-1 CA M66Ahomo-60-mer133-353
99.55120×IHP;
T=1 particle HIV-1 CA G60A/G61P/M66Ahomo-60-mer133-353
98.64120×IHP;
Structure of HIV-1 capsid declinationhomo-35-mer133-353
10010×IHP;
Immature HIV-1 matrix structurehomo-24-mer2-116
10024×MYR;
Mature HIV-1 matrix structurehomo-24-mer2-116
10024×MYR; 24×PIO;
Gag CA-SP1 immature lattice bound with Lenacapavir from enveloped virus like particleshomo-18-mer143-371
99.5618×QNG;IHP;
Gag CA-SP1 immature lattice bound with Bevirimat from enveloped virus like particleshomo-18-mer144-371
99.56IHP;2I4;
Gag CA-SP1 immature lattice from enveloped and perforated virus like particleshomo-18-mer144-371
99.56IHP;
An atomic model of HIV-1 CA-SP1 reveals structures regulating assembly and maturationhomo-18-mer148-371
100
E45A/R132T mutant of HIV-1 capsid proteinhomo-6-mer133-353
99.0748×IOD; 42×CL;
Structure of the R18A mutant of the HIV-1 capsid proteinhomo-6-mer133-353
99.5454×IOD; 42×CL;
Structure of the E28A mutant of the HIV-1 capsid proteinhomo-6-mer133-353
99.5472×IOD; 36×CL;
E45A mutant of HIV-1 capsid protein (other crystal form)homo-6-mer133-353
99.5560×IOD; 24×CL;
Structure of the R18A/E28A mutant of the HIV-1 capsid proteinhomo-6-mer133-353
99.0842×IOD; 42×CL;
Structure of the P122A mutant of the HIV-1 capsid proteinhomo-6-mer133-353
99.5448×IOD; 30×CL;
Hexameric HIV-1 (M-group) CA R120 mutanthomo-6-mer133-353
10012×IOD; 30×CL;BME;
Structure of the T58S/T107I/P122A mutant of the HIV-1 capsid proteinhomo-6-mer133-353
98.6254×IOD; 36×CL;
Structure of the V11I/T58A/P122A mutant of the HIV-1 capsid proteinhomo-6-mer133-353
98.6160×IOD; 36×CL;
P38A mutant of HIV-1 capsid proteinhomo-6-mer133-353
99.5448×IOD; 30×CL;
Structure of the native full-length HIV-1 capsid proteinhomo-6-mer133-353
100.042×IOD; 12×CL;
E45A mutant of the HIV-1 capsid proteinhomo-6-mer133-353
99.5518×IOD; 72×CL;
P38A/T216I mutant of the HIV-1 capsid proteinhomo-6-mer133-353
99.0936×IOD; 36×CL;
N74D mutant of the HIV-1 capsid protein in complex with PF-3450074 (PF74)homo-6-mer133-353
99.551B0; 36×IOD;
HIV-1 CA hexamer in complex with IP6, orthorhombic crystal formhomo-6-mer133-353
98.17IHP;
Structure of the wild-type native full-length HIV-1 capsid protein in complex with ZW-1261homo-6-mer133-353
100YTG; 30×IOD;
Structure of the native full-length HIV-1 capsid protein in complex with PF-3450074 (PF74)homo-6-mer133-353
100.036×IOD; 12×CL;1B0;
Structure of the T58S/T107I/P122A mutant of the HIV-1 capsid protein in complex with PF-3450074 (PF…homo-6-mer133-353
98.6130×IOD; 54×CL;1B0;
Structure of the V11I/T58A/I124A mutant of the HIV-1 capsid proteinhomo-6-mer133-353
98.6142×IOD; 54×CL;
N74D mutant of the HIV-1 capsid proteinhomo-6-mer133-353
99.5436×IOD;
Structure of HIV-1 CA 1/2-hexamerhomo-6-mer133-353
98.64NA;
Structure of HIV-1 CA P207Shomo-6-mer133-353
99.5318×IOD; 12×CL;
Structure of HIV-1 CA G208Rhomo-6-mer133-353
99.5412×IOD;
Structure of HIV-1 CA T210Khomo-6-mer133-353
99.5412×IOD; 12×CL;
HIV-1 mature capsid hexamer from CA-IP6 CLPshomo-6-mer133-353
100.0
CryoEM Structure Refinement by Integrating NMR Chemical Shifts with Molecular Dynamics Simulationshomo-6-mer133-353
100
HIV-1 mature capsid hexamer next to pentamer (type I) from CA-IP6 CLPshomo-6-mer133-353
100.0
Co-crystal structure of GS-6207 bound to HIV-1 capsid hexamerhomo-6-mer133-352
98.18QNG; 12×IOD; 24×CL;
Structure of M66I mutant of disulfide stabilized HIV-1 CA hexamerhomo-6-mer133-352
97.7218×IOD; 21×CL;
Structure of the I124A mutant of the HIV-1 capsid proteinhomo-6-mer133-352
99.5354×IOD; 60×CL;
Structure of the T58A/I124A mutant of the HIV-1 capsid proteinhomo-6-mer133-352
99.0648×IOD; 54×CL;
Structure of the native full-length dehydrated HIV-1 capsid proteinhomo-6-mer133-352
100.012×CL;1PE;
Co-crystal structure of lenacapavir bound to N74D mutant of disulfide stabilized HIV-1 CA hexamerhomo-6-mer133-352
97.72QNG; 36×CL;IOD;
Hexamer of Helical HIV capsid by RASTR methodhomo-6-mer133-352
99.55
Hexameric HIV-1 CA in complex with DDD00100439homo-6-mer133-351
98.1712×EDO;WVU;
Hexameric HIV-1 CA in complex with DDD00057456homo-6-mer133-351
98.17AJ2;
Potent long-acting inhibitors targeting HIV-1 capsid based on a versatile quinazolin-4-one scaffoldhomo-6-mer133-351
98.1715×EDO;Y05;
Hexameric HIV-1 CA in complex with DDD00100452homo-6-mer133-351
98.1724×EDO;WWR;
Hexameric HIV-1 CA in complex with DDD00074110homo-6-mer133-351
98.17WVZ;
Hexameric HIV-1 CA in complex with DDD00100555homo-6-mer133-351
98.173IP;
Hexameric HIV-1 CA in complex with DDD00024969homo-6-mer133-351
98.17XXL;
Hexameric HIV-1 CA H12Y mutanthomo-6-mer133-351
98.56
Hexameric HIV-1 CA in complex with DDD01829021homo-6-mer133-351
98.16WZL; 18×EDO;
Hexameric HIV-1 CA in complex with DDD01728501homo-6-mer133-351
98.17X0L;EDO;
Hexameric HIV-1 CA, apo formhomo-6-mer133-351
99.02
Hexameric HIV-1 CA in complex with hexacarboxybenzenehomo-6-mer133-351
99.02BHC;
Disulfide stabilized HIV-1 CA hexamer 4mut (S41A, Q67H, V165I, L172I) in complex with PF-3450074homo-6-mer133-351
96.741B0;
HIV-1 CA hexamer in complex with IP6, hexagonal crystal formhomo-6-mer133-351
99.03IHP;
Crystal structure of the HIV capsid hexamer bound to the small molecule long-acting inhibitor, GS-6…homo-6-mer133-351
98.06QNG;
Hexameric HIV-1 CA R18G mutanthomo-6-mer133-351
98.54
HIV capsid hexamer with IP6 ligandhomo-6-mer133-351
99.02IHP;
Hexameric HIV-1 CA in complex with DDD01829894homo-6-mer133-351
98.1712×EDO;WZ9;
Disulfide stabilized HIV-1 CA hexamer 4mut (S41A, Q67H, V165I, L172I)homo-6-mer133-351
97.16
Hexameric HIV-1 CA in complex with DDD01044153homo-6-mer133-351
98.17WZR;EDO;
Hexameric HIV-1 CA in complex with dATPhomo-6-mer133-351
99.01DTP;
Hexameric HIV-1 CA in complex with PF3450074homo-6-mer133-351
99.04CL;1B0;
HIV-1 capsid hexamer R18D mutanthomo-6-mer133-351
97.69
Structure of Q67H mutant of disulfide stabilized HIV-1 CA hexamerhomo-6-mer133-351
98.5736×IOD; 24×CL;
Structure of Q67H/N74D mutant of disulfide stabilized HIV-1 CA hexamerhomo-6-mer133-351
97.2624×IOD; 30×CL;
Hexameric HIV-1 CA in complex with DDD01728505homo-6-mer133-351
98.16X0H;
Hexameric HIV-1 CA in Complex with BI-2homo-6-mer133-351
99.0EDO;3A8;
Hexameric HIV-1 CA in complex with DDD00100333homo-6-mer133-351
98.1512×EDO;S0I;
Co-crystal structure of lenacapavir bound to Q67H/N74D mutant of disulfide stabilized HIV-1 CA hexa…homo-6-mer133-351
98.09QNG; 24×CL;IOD;
Co-crystal structure of Q67H mutant of disulfide stabilized HIV-1 CA hexamer and lenacapavirhomo-6-mer133-351
98.55QNG; 18×IOD; 24×CL;
Hexameric HIV-1 CA in complex with DDD01728503homo-6-mer133-351
98.1512×EDO;WZX;
HIV capsid hexamer with IP5 ligandhomo-6-mer133-351
99.02
Hexameric HIV-1 CA, open conformationhomo-6-mer133-351
98.551B0;CL;
Hexameric HIV-1 (M-group) CA Q50Y mutanthomo-6-mer133-351
97.72
X-ray Structure of Hexameric HIV-1 CAhomo-6-mer133-351
99.09
Disulfide-stabilized HIV-1 CA hexamer in complex with PQBP1 Nthomo-6-mer133-351
98.09
Immature HIV-1 CACTD-SP1 lattice with Bevirimat (BVM) and Inositol hexakisphosphate (IP6)homo-6-mer278-377
99.0IHP;2I4;
Immature HIV-1 CACTD-SP1 lattice with Inositol hexakisphosphate (IP6)homo-6-mer278-377
99.0IHP;
Crystal structure of Pr55Gag-matrix domain in complex with IP6 in space group C121homo-3-mer1-116
100IHP;
Crystal Structure Human Immunodeficiency Virus-1 Matrix protein Mutant Q63R Crystal Form 2homo-3-mer7-116
99.0412P;SO4;ACT;
X-ray structure of the HIV-1 myristoylated matrix proteinhomo-3-mer2-109
100MYR;1PE;CIT;
Crystal Structure Human Immunodeficiency Virus-1 Matrix protein Mutant Q63R Crystal Form 1homo-3-mer7-111
99.04P6G;SO4;
Hexamer-2-Foldon HIV-1 capsid platformhomo-2-mer133-353
99.05
Structure of HIV-1 CA 1/3-hexamerhomo-2-mer133-351
98.11ACT;
Dimerization interface of the noncrystalline HIV-1 capsid protein lattice from solid state NMR spec…homo-2-mer307-325
100
Atomic-Resolution Structure of HIV-1 Capsid Tubes by Magic Angle Spinning NMRmonomer133-363
100
Structure of HIV-1 CAcSP1NC mutant(W41A,M42A) interacting with maturation inhibitor EP39monomer276-432
98.73ZN;
STRUCTURE OF THE N-TERMINAL DOMAIN OF THE MATURE HIV-1 CAPSID PROTEINmonomer133-283
100
Solution structures of HIV-1 and SIVmac p6 and their interaction with accessory proteins Vpr and Vp…monomer449-500
100
Solution Structure of the Human Immunodeficiency Virus Type 1 p6 Proteinmonomer449-500
100

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
9clj.1.Amonomer0.73133-354
66.52
1l6n.1.Amonomer0.702-283
100.00
7asl.1.Amonomer0.67143-377
97.87
1esk.1.Amonomer0.57389-430
ZN;92.86